Gene · 762
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Risk factors and actionable molecular signatures in COVID-19-associated lung adenocarcinoma and lung squamous cell carcinoma patients. | Comput Biol Med | 2023 | 37040675 | PubTator, text mining | PubMed |
| Treponemal Antibody Seroprevalence Using a Multiplex Bead Assay from Samples Collected during the 2018 Nigeria HIV/AIDS Indicator and Impact Survey: Searching for Yaws in Nigeria. | Am J Trop Med Hyg | 2023 | 37037444 | PubTator, text mining | PubMed |
| Cellular heterogeneity and stem cells of vascular endothelial cells in blood vessel formation and homeostasis: Insights from single-cell RNA sequencing. | Front Cell Dev Biol | 2023 | 37025170 | PubTator, text mining | PubMed |
| In-depth proteomic signature of parathyroid carcinoma. | Eur J Endocrinol | 2023 | 36995894 | PubTator, text mining | PubMed |
| Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents. | BMC Med Genomics | 2023 | 36991484 | PubTator, text mining | PubMed |
| ceRNA network construction and identification of hub genes as novel therapeutic targets for age-related cataracts using bioinformatics. | PeerJ | 2023 | 36987450 | PubTator, text mining | PubMed |
| Analogues of Anticancer Natural Products: Chiral Aspects. | Int J Mol Sci | 2023 | 36982753 | PubTator, text mining | PubMed |
| The ethyl acetate extract of Wenxia Changfu Formula inhibits the carcinogenesis of lung adenocarcinoma by regulating PI3K-AKT signaling pathway. | Sci Rep | 2023 | 36949111 | PubTator, text mining | PubMed |
| Carbonic Anhydrase 4 Serves as A Novel Prognostic Biomarker and Therapeutic Target for Non-Small Cell Lung Cancer: A Study Based on TCGA Samples. | Comb Chem High Throughput Screen | 2023 | 36944625 | PubTator, text mining | PubMed |
| Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma. | Open Med (Wars) | 2023 | 36941988 | PubTator, text mining | PubMed |
| Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors. | J Enzyme Inhib Med Chem | 2023 | 36938694 | PubTator, text mining | PubMed |
| Research progress on antitumor activity of XRP44X and analogues as microtubule targeting agents. | Front Chem | 2023 | 36936533 | PubTator, text mining | PubMed |
| The Multifarious Effects of Various Glaucoma Pharmacotherapy on Corneal Endothelium: A Narrative Review. | Ophthalmol Ther | 2023 | 36930417 | PubTator, text mining | PubMed |
| Serum Chloride and Heart Failure. | Kidney Med | 2023 | 36911181 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Untargeted Approaches to Reveal Diagnostic Signatures of Male Infertility in Seminal Plasma: A New Laboratory Perspective for the Clinical Management of Infertility? | Int J Mol Sci | 2023 | 36901856 | PubTator, text mining | PubMed |
| Unveil the Secret of the Bacteria and Phage Arms Race. | Int J Mol Sci | 2023 | 36901793 | PubTator, text mining | PubMed |
| Developmental diversity and unique sensitivity to injury of lung endothelial subtypes during postnatal growth. | iScience | 2023 | 36879800 | PubTator, text mining | PubMed |
| Synthesis and biological evaluation of new 3-substituted coumarin derivatives as selective inhibitors of human carbonic anhydrase IX and XII. | J Enzyme Inhib Med Chem | 2023 | 36876597 | PubTator, text mining | PubMed |
| Comprehensive characterization of the embryonic factor LEUTX. | iScience | 2023 | 36876139 | PubTator, text mining | PubMed |
| Selective carbonic anhydrase IX and XII inhibitors based around a functionalized coumarin scaffold. | Drug Dev Res | 2023 | 36872587 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/762/papers?page=15